Physician

Dwight M Matthew, M.D.

According to 2025 Medicare claims, Dwight Matthew, M.D. (NPI: 1922261304) practices nephrology in the Florence-Muscle Shoals, AL market, with the plurality of this provider's patient population coming from Lauderdale, AL. This provider's primary affiliated billing organization is N RAO BOORGU MD PC (NPI: 1780641951; TIN: 630794660) and primary practice location at 35630-5707. Matthew is affiliated with the Huntsville ACO (ACO ID: A3579) and AdvantagePoint Health Alliance - Tennessee Valley, LLC (ACO ID: A5038), participating under the MSSP model.

Matthew's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 461 traditional Medicare patients, billed 14,653 HCPCS/CPT codes, and received $293,392 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 1,973 prescription claims across 314 beneficiaries totaling $292,198 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 16 claims. Open Payments data shows 23 records totaling $638. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $734,999 to $293,392. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $436,913 to $292,198. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,173 and ending at $5,846.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,595	104,179	$734,999
2016	1,389	122,387	$808,232
2017	896	45,951	$551,511
2018	829	30,276	$515,873
2019	809	14,277	$451,525
2020	721	12,865	$442,336
2021	679	11,692	$393,918
2022	599	13,686	$345,131
2023	558	12,901	$338,874
2024	461	14,653	$293,392

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	551	4,091	$436,913
2016	623	4,813	$518,376
2017	541	4,203	$402,957
2018	458	3,697	$341,730
2019	369	2,587	$234,083
2020	339	2,491	$233,578
2021	334	2,083	$174,021
2022	319	1,895	$194,437
2023	351	1,945	$332,986
2024	314	1,973	$292,198

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	72	$3,296
2016	16	155	$7,459
2017	12	128	$6,464
2018	15	216	$7,710
2019	13	96	$2,242
2020	11	64	$735
2021	N/R	39	$1,677
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	16	$5,583

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	258	562	$10
36415	Insertion of needle into vein for collection of blood sample	259	637	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	257	579	$8
84100	Phosphate level	257	558	$5
84550	Uric acid level, blood	257	554	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	83	3,420	$61,130
Velphoro	Sucroferric Oxyhydroxide	12	324	$52,014
Kerendia	Finerenone	15	750	$15,789
Jardiance	Empagliflozin	17	810	$14,057
Januvia	Sitagliptin Phosphate	16	660	$12,251

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	16	$5,583

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$638	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dwight M. Matthew, M.D.?

Tedicare shows public-source Medicare data for Dwight M. Matthew, M.D. (NPI 1922261304), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dwight M. Matthew, M.D. have ACO affiliation data?

Dwight M. Matthew, M.D. is shown with ACO affiliation data for Huntsville ACO (MSSP, ACO ID A3579) and AdvantagePoint Health Alliance - Tennessee Valley, LLC (MSSP, ACO ID A5038).

What billing organization is linked to Dwight M. Matthew, M.D.?

Dwight M. Matthew, M.D. is linked to N RAO BOORGU MD PC (billing NPI 1780641951) in the available physician profile data.

Does Dwight M. Matthew, M.D. have Open Payments data?

Dwight M. Matthew, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.